Literature DB >> 18039119

Pathogenesis of nonimmune glomerulopathies.

Christopher Kwoh1, M Brendan Shannon, Jeffrey H Miner, Andrey Shaw.   

Abstract

Nonimmune glomerulopathies are an area of significant research. This review discusses the development of focal segmental glomerulosclerosis, with particular attention to the role of the podocyte in the initiation of glomerulosclerosis and the contribution to glomerulosclerosis from capillary hypertension and soluble factors such as transforming growth factor beta, platelet-derived growth factor, vascular endothelial growth factor, and angiotensin. The effects of these factors on endothelial and mesangial cells are also discussed. In addition, we review our current understanding of the slit diaphragm (a specialized cell junction found in the kidney), slit diaphragm-associated proteins (including nephrin, podocin, alpha-actinin-4, CD2-associated protein, and transient receptor potential channel 6), and the role of these proteins in glomerular disease. We also discuss the most recent research on the pathogenesis of collapsing glomerulosclerosis, human immunodeficiency virus associated nephropathy, Denys-Drash, diabetic nephropathy, Alport syndrome, and other diseases related to the interaction between the podocyte and the glomerular basement membrane.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 18039119     DOI: 10.1146/annurev.pathol.1.110304.100119

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  29 in total

1.  Protective effects of low-dose rapamycin combined with valsartan on podocytes of diabetic rats.

Authors:  Jin Zhang; Xiaozhou Hu; Shaoting Wang; Yan Zhang; Hong Yang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription.

Authors:  Johannes Schlöndorff; Donato Del Camino; Robert Carrasquillo; Vanessa Lacey; Martin R Pollak
Journal:  Am J Physiol Cell Physiol       Date:  2009-01-07       Impact factor: 4.249

3.  A novel assay to assess the effect of pharmaceutical compounds on the differentiation of podocytes.

Authors:  Frances Kindt; Elke Hammer; Stefan Kemnitz; Antje Blumenthal; Paul Klemm; Rabea Schlüter; Susan E Quaggin; Jens van den Brandt; Georg Fuellen; Uwe Völker; Karlhans Endlich; Nicole Endlich
Journal:  Br J Pharmacol       Date:  2016-12-20       Impact factor: 8.739

4.  Enhanced podocyte vesicle transport in the nephrotic rat.

Authors:  Akihiro Tojo; Saaya Hatakeyama; Satoshi Kinugasa; Satoru Fukuda; Toshio Sakai
Journal:  Med Mol Morphol       Date:  2017-03-17       Impact factor: 2.309

5.  ARB protects podocytes from HIV-1 nephropathy independently of podocyte AT1.

Authors:  Akihiro Shimizu; Jianyong Zhong; Yoichi Miyazaki; Tatsuo Hosoya; Iekuni Ichikawa; Taiji Matsusaka
Journal:  Nephrol Dial Transplant       Date:  2012-03-15       Impact factor: 5.992

6.  Keap1 inhibition attenuates glomerulosclerosis.

Authors:  Yoichi Miyazaki; Akihiro Shimizu; Ira Pastan; Keiko Taguchi; Eriko Naganuma; Takafumi Suzuki; Tatsuo Hosoya; Takashi Yokoo; Akihiko Saito; Toshio Miyata; Masayuki Yamamoto; Taiji Matsusaka
Journal:  Nephrol Dial Transplant       Date:  2014-02-11       Impact factor: 5.992

Review 7.  mTOR inhibitors and renal allograft: Yin and Yang.

Authors:  Gianluigi Zaza; Simona Granata; Paola Tomei; Valentina Masola; Giovanni Gambaro; Antonio Lupo
Journal:  J Nephrol       Date:  2014-05-08       Impact factor: 3.902

8.  Systematic analysis of a novel human renal glomerulus-enriched gene expression dataset.

Authors:  Maja T Lindenmeyer; Felix Eichinger; Kontheari Sen; Hans-Joachim Anders; Ilka Edenhofer; Deborah Mattinzoli; Matthias Kretzler; Maria P Rastaldi; Clemens D Cohen
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

9.  Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders.

Authors:  Laura Lasagni; Lara Ballerini; Maria Lucia Angelotti; Eliana Parente; Costanza Sagrinati; Benedetta Mazzinghi; Anna Peired; Elisa Ronconi; Francesca Becherucci; Daniele Bani; Mauro Gacci; Marco Carini; Elena Lazzeri; Paola Romagnani
Journal:  Stem Cells       Date:  2010-09       Impact factor: 6.277

10.  Adiponectin promotes functional recovery after podocyte ablation.

Authors:  Joseph M Rutkowski; Zhao V Wang; Ae Seo Deok Park; Jianning Zhang; Dihua Zhang; Ming Chang Hu; Orson W Moe; Katalin Susztak; Philipp E Scherer
Journal:  J Am Soc Nephrol       Date:  2013-01-18       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.